Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

HIV Infection

Free Subscription Articles published in PLoS Med Retrieve available abstracts of 46 articles: HTML format

Single Articles

June 2026
1. LIU YE, Bampi JVB, Arthur RF, Salindri AD, et al
   Comparative impacts and cost-effectiveness of tuberculosis systematic screening strategies in prisons in Brazil, Colombia, and Peru: A mathematical modeling study.
   PLoS Med. 2026;23:e1004739.
   PubMed     Abstract available
   
   
   May 2026
2. SWARTWOOD NA, Singh N, Mortazavi SA, Can MH, et al
   Differences in tuberculosis prevalence by sex in low- and middle-income countries over 1993-2025: A systematic review and meta-analysis.
   PLoS Med. 2026;23:e1005114.
   PubMed     Abstract available
   
   
   
3. ELSBERND K, Sabi I, Jani IV, Mudenyanga C, et al
   Point-of-care early infant HIV diagnosis at birth in a pragmatic cluster-randomized trial in Mozambique and Tanzania: A comparative cost and cost-effectiveness study.
   PLoS Med. 2026;23:e1005069.
   PubMed     Abstract available
   
   
   
4. ARATRIKA A, Doyle CM, Johnson CC, Edun O, et al
   Trends in HIV self-testing uptake in Africa: A modeling study of population-based surveys and HIV testing program data.
   PLoS Med. 2026;23:e1004771.
   PubMed     Abstract available
   
   
   
5. TORRES TS, Luz PM
   U = U for all: Advancing equity in HIV prevention.
   PLoS Med. 2026;23:e1005090.
   PubMed     Abstract available
   
   
   April 2026
6. TIEOSAPJAROEN W, Williams E, Johnson CC, Baptista Da Silva C, et al
   Rapid diagnostic tests, laboratory-based immunoassay and nucleic acid testing strategies for long-acting injectable pre-exposure prophylaxis: A systematic review.
   PLoS Med. 2026;23:e1005030.
   PubMed     Abstract available
   
   
   
7. SU JS, Stover J, Pretorius C, Winskill P, et al
   The benefits of investments to combat HIV, tuberculosis, and malaria for primary healthcare from 2000 to 2023: An economic modeling analysis.
   PLoS Med. 2026;23:e1005036.
   PubMed     Abstract available
   
   
   March 2026
8. AKULLIAN A, Ssempijja V, Breidenbecker D, Nalugoda F, et al
   Evaluating the biomedical and behavioral drivers of HIV incidence decline in adolescent girls and young women in Uganda: A mathematical modeling study.
   PLoS Med. 2026;23:e1004993.
   PubMed     Abstract available
   
   
   
9. MUKASA D, Kinuthia J, Meisner A, Matemo D, et al
   Oral preexposure prophylaxis use and the risk of bacterial sexually transmitted infections and HIV among African women: A prospective observational cohort study.
   PLoS Med. 2026;23:e1004962.
   PubMed     Abstract available
   
   
   
10. ORTBLAD KF, Wairimu N, Culquichicon C, Njeru I, et al
    Effect of enhanced peer PrEP referral with HIV self-testing delivery among young Kenyan women: A randomized controlled trial of peer networks.
    PLoS Med. 2026;23:e1005023.
    PubMed     Abstract available
    
    
    February 2026
11. DUROVNI B, Cordeiro-Santos M, Cavalcante SC, Spener-Gomes R, et al
    Acceptability and safety of one versus three months of rifapentine and isoniazid to prevent tuberculosis in people exposed in the household or workplace in Brazil: The Ultra-Curto randomized controlled trial.
    PLoS Med. 2026;23:e1004758.
    PubMed     Abstract available
    
    
    
12. LI Q, Zhou J, Xu Y, Zou H, et al
    Medication adherence and its associated factors among oral pre-exposure prophylaxis (PrEP) users in China: The Real-world E-consumer Cohort of PrEP study.
    PLoS Med. 2026;23:e1004733.
    PubMed     Abstract available
    
    
    December 2025
13. FAUCI AS, Folkers GK
    Treatment and prevention of HIV/AIDS: Unfinished business.
    PLoS Med. 2025;22:e1004806.
    PubMed     Abstract available
    
    
    
14. MCLAUGHLIN A, Toy J, Montoya V, Sereda P, et al
    Heterogeneous impacts of HIV pre-exposure prophylaxis (PrEP) on drug resistance and phylogenetic cluster transmission dynamics in British Columbia, Canada: A retrospective cohort and simulation study.
    PLoS Med. 2025;22:e1004827.
    PubMed     Abstract available
    
    
    
15. JOHNSON LF, Jamieson L, Kubjane M, Meyer-Rath G, et al
    Evaluation of economic strengthening in South Africa and its impact on HIV, sexually transmitted infections, and teenage births: A modelling study.
    PLoS Med. 2025;22:e1004826.
    PubMed     Abstract available
    
    
    November 2025
16. OLBRICH L, Larsson L, Dunbar R, Dodd PJ, et al
    Diagnostic accuracy of the WHO tuberculosis treatment decision algorithms for children with presumptive tuberculosis: An individual participant data meta-analysis.
    PLoS Med. 2025;22:e1004610.
    PubMed     Abstract available
    
    
    October 2025
17. TIWARI R, Singa BO, Lihanda P, Diakhate MM, et al
    Differences in growth trajectories in breastfed HIV-exposed uninfected and HIV-unexposed infants in Kenya: An observational cohort study.
    PLoS Med. 2025;22:e1004781.
    PubMed     Abstract available
    
    
    September 2025
18. SKRIVANKOVA VW, Rabie S, Tlali M, Folb N, et al
    Incidence and prognostic factors of self-harm and subsequent unnatural death in South Africa: A cohort study.
    PLoS Med. 2025;22:e1004765.
    PubMed     Abstract available
    
    
    
19. MUGWANY KK, Saina M, Mugo NR, MaWhinney S, et al
    Adherence thresholds for emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis against HIV acquisition in cisgender women: A randomized directly observed dosing study.
    PLoS Med. 2025;22:e1004732.
    PubMed     Abstract available
    
    
    
20. SIKOMBE K, Le Tourneau N, Rice B, Pry JM, et al
    Identifying care gaps along the HIV treatment failure cascade: A multistate analysis of viral load monitoring, re-suppression, and regimen switches in Zambia.
    PLoS Med. 2025;22:e1004720.
    PubMed     Abstract available
    
    
    August 2025
21. HUBER AN, Jamieson L, Fox MP, Manganye M, et al
    Evaluating the impact of differentiated service delivery (DSD) on retention in care and HIV viral suppression in South Africa: A target trial emulation using routine healthcare data.
    PLoS Med. 2025;22:e1004489.
    PubMed     Abstract available
    
    
    
22. TOH W, Lepine A, Gueye K, Fall MM, et al
    Effect of pre-exposure prophylaxis on risky sexual behaviour of female sex workers in Dakar, Senegal: A randomised controlled trial.
    PLoS Med. 2025;22:e1004458.
    PubMed     Abstract available
    
    
    July 2025
23. ADJOBIMEY M, Trajman A, Bastos ML, Valiquette C, et al
    Rapid molecular testing or chest X-ray or tuberculin skin testing for household contact assessment of tuberculosis infection: A cluster-randomized trial.
    PLoS Med. 2025;22:e1004666.
    PubMed     Abstract available
    
    
    June 2025
24. HICKEY MD, Owaraganise A, Ogachi S, Sang N, et al
    Community health worker-facilitated telehealth for moderate-severe hypertension care in Kenya and Uganda: A randomized controlled trial.
    PLoS Med. 2025;22:e1004632.
    PubMed     Abstract available
    
    
    May 2025
25. FERALDI A, Zarulli V, Buse K, Hawkes S, et al
    Sex-disaggregated data along the gendered health pathways: A review and analysis of global data on hypertension, diabetes, HIV, and AIDS.
    PLoS Med. 2025;22:e1004592.
    PubMed     Abstract available
    
    
    April 2025
26. SI Y, Guo L, Chen S, Zhang X, et al
    Progressing towards the 2030 health-related SDGs in ASEAN: A systematic analysis.
    PLoS Med. 2025;22:e1004551.
    PubMed     Abstract available
    
    
    January 2025
27. HICKEY MD, Ayieko J, Kabami J, Owaraganise A, et al
    Cost-effectiveness of leveraging existing HIV primary health systems and community health workers for hypertension screening and treatment in Africa: An individual-based modeling study.
    PLoS Med. 2025;22:e1004531.
    PubMed     Abstract available
    
    
    
28. KIM S, Can MH, Agizew TB, Auld AF, et al
    Factors associated with tuberculosis treatment initiation among bacteriologically negative individuals evaluated for tuberculosis: An individual patient data meta-analysis.
    PLoS Med. 2025;22:e1004502.
    PubMed     Abstract available
    
    
    December 2024
29. GONZALEZ R, Nhampossa T, Figueroa-Romero A, Tchouatieu AM, et al
    Protecting the most vulnerable: The urgent need to include HIV-exposed children in malaria chemoprevention strategies.
    PLoS Med. 2024;21:e1004498.
    PubMed     Abstract available
    
    
    October 2024
30. PIPER JD, Mazhanga C, Mwapaura M, Mapako G, et al
    Growth, physical, and cognitive function in children who are born HIV-free: School-age follow-up of a cluster-randomised trial in rural Zimbabwe.
    PLoS Med. 2024;21:e1004347.
    PubMed     Abstract available
    
    
    
31. LEPINE A, Szawlowski S, Nitcheu E, Cust H, et al
    The effect of protecting women against economic shocks to fight HIV in Cameroon, Africa: The POWER randomised controlled trial.
    PLoS Med. 2024;21:e1004355.
    PubMed     Abstract available
    
    
    
32. HEITNER J, Mwenda V, Umutesi G, Barnabas RV, et al
    Leveraging behavioral economics strategies to close gaps in biomedical HIV prevention.
    PLoS Med. 2024;21:e1004475.
    PubMed     Abstract available
    
    
    September 2024
33. CALDERWOOD CJ, Marambire ET, Larsson L, Banze D, et al
    HIV, malnutrition, and noncommunicable disease epidemics among tuberculosis-affected households in east and southern Africa: A cross-sectional analysis of the ERASE-TB cohort.
    PLoS Med. 2024;21:e1004452.
    PubMed     Abstract available
    
    
    August 2024
34. ODHIAMBO F, Onyango R, Mulwa E, Aluda M, et al
    Evaluation of person-centered interventions to eliminate perinatal HIV transmission in Kisumu County, Kenya: A repeated cross-sectional study using aggregated registry data.
    PLoS Med. 2024;21:e1004441.
    PubMed     Abstract available
    
    
    
35. GENG EH, Mocumbi A, Mutale W, Davila-Roman V, et al
    Primary care to further improve vertical HIV programming outcomes: From spillover to strategy.
    PLoS Med. 2024;21:e1004434.
    PubMed    
    
    
    July 2024
36. BONNET G, Bimba J, Chavula C, Chifamba HN, et al
    Cost-effectiveness of COVID rapid diagnostic tests for patients with severe/critical illness in low- and middle-income countries: A modeling study.
    PLoS Med. 2024;21:e1004429.
    PubMed     Abstract available
    
    
    
37. PINTO PFPS, Macinko J, Silva AF, Lua I, et al
    The impact of primary health care on AIDS incidence and mortality: A cohort study of 3.4 million Brazilians.
    PLoS Med. 2024;21:e1004302.
    PubMed     Abstract available
    
    
    June 2024
38. WALSH SR, Gay CL, Karuna ST, Hyrien O, et al
    Safety and pharmacokinetics of VRC07-523LS administered via different routes and doses (HVTN 127/HPTN 087): A Phase I randomized clinical trial.
    PLoS Med. 2024;21:e1004329.
    PubMed     Abstract available
    
    
    May 2024
39. EUVRARD J, Timmerman V, Keene CM, Phelanyane F, et al
    The cyclical cascade of HIV care: Temporal care engagement trends within a population-wide cohort.
    PLoS Med. 2024;21:e1004407.
    PubMed     Abstract available
    
    
    
40. VAN DEN ELSHOUT MAM, Wijstma ES, Boyd A, Jongen VW, et al
    Sexual behaviour and incidence of sexually transmitted infections among men who have sex with men (MSM) using daily and event-driven pre-exposure prophylaxis (PrEP): Four-year follow-up of the Amsterdam PrEP (AMPrEP) demonstration project cohort.
    PLoS Med. 2024;21:e1004328.
    PubMed     Abstract available
    
    
    
41. MICHALOW J, Walters MK, Edun O, Wybrant M, et al
    Aetiology of vaginal discharge, urethral discharge, and genital ulcer in sub-Saharan Africa: A systematic review and meta-regression.
    PLoS Med. 2024;21:e1004385.
    PubMed     Abstract available
    
    
    
42. TELISINGHE L, Floyd S, MacLeod D, Schaap A, et al
    Incidence of self-reported tuberculosis treatment with community-wide universal testing and treatment for HIV and tuberculosis screening in Zambia and South Africa: A planned analysis of the HPTN 071 (PopART) cluster-randomised trial.
    PLoS Med. 2024;21:e1004393.
    PubMed     Abstract available
    
    
    April 2024
43. CHEN L, Xing Y, Zhang Y, Xie J, et al
    Long-term variations of urban-Rural disparities in infectious disease burden of over 8.44 million children, adolescents, and youth in China from 2013 to 2021: An observational study.
    PLoS Med. 2024;21:e1004374.
    PubMed     Abstract available
    
    
    March 2024
44. EMANI S, Alves K, Alves LC, da Silva DA, et al
    Quantifying gaps in the tuberculosis care cascade in Brazil: A mathematical model study using national program data.
    PLoS Med. 2024;21:e1004361.
    PubMed     Abstract available
    
    
    
45. MOODIE Z, Andersen-Nissen E, Grunenberg N, Dintwe OB, et al
    Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial.
    PLoS Med. 2024;21:e1004360.
    PubMed     Abstract available
    
    
    
46. BRAZIER E, Tymejczyk O, Wools-Kaloustian K, Jiamsakul A, et al
    Long-term HIV care outcomes under universal HIV treatment guidelines: A retrospective cohort study in 25 countries.
    PLoS Med. 2024;21:e1004367.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum